ACCC appeals $1.7m penalty against Reckitt Benckiser for misleading Nurofen representations

ACCC, statement 23 May 2016
“The Australian Competition and Consumer Commission has filed a Notice of Appeal from the Federal Court’s decision ordering Reckitt Benckiser to pay penalties of $1.7 million for contravening the Australian Consumer Law. In December 2015, following admissions by Reckitt Benckiser, the Court found that Reckitt Benckiser engaged in misleading or deceptive conduct by making representations on its website and product packaging that Nurofen Specific Pain products were each formulated to specifically treat a particular type of pain, when this was not the case.”
Find ACCC statement here. Find ABC News article ‘ACCC seeks $6m fine against Nurofen maker for misleading consumers‘.